Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

Journal Article

2019-01-14

Permanent link to this Item
https://doi.org/10.1186/s13063-018-3155-9
 http://hdl.handle.net/11427/29340
Files
Lawrence_2018_Article.pdf (239.64 KB)
Authors
Lawrence, David S
Youssouf, Nabila
Hope, William
Hosseinipour, Mina C
Kanyama, Cecilia
Lortholary, Oliver
Loyse, Angela
Meya, David B
Mosepele, Mosepele
Muzoora, Conrad
Mwandumba, Henry C
Ndhlovu, Chiratidzo E
Molloy, Síle F
Niessen, Louis
Schutz, Charlotte
Stott, Katharine E
Wang, Duolao
Lalloo, David G
Meintjes, Graeme
Jaffar, Shabbar
Harrison, Thomas S
Jarvis, Joseph N
Alanio, Alexandre
Alufandika, Melanie
Boulware, David R
Boyer-Chammard, Timothée
Chen, Tao
Dromer, Francoise
Hlupeni, Admire
Journal Title
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher
License
Series
Abstract
Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.
Description

Reference:

Lawrence, D. S., Youssouf, N., Molloy, S. F., Alanio, A., Alufandika, M., Boulware, D. R., ... & Hope, W. (2019). Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial. Trials, 20(1), 48.

Collections
Journal Articles